136 related articles for article (PubMed ID: 8702455)
41. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
[TBL] [Abstract][Full Text] [Related]
42. Antibodies against SS-B/La and SS-A/Ro antigens in patients with primary Sjögren's syndrome.
Hansen B; Manthorpe R
Scand J Rheumatol Suppl; 1986; 61():93-7. PubMed ID: 3495875
[TBL] [Abstract][Full Text] [Related]
43. Effect of steroid administration and plasmapheresis to prevent fetal congenital heart block in patients with systemic lupus erythematosus and/or Sjögren's syndrome.
Makino S; Yonemoto H; Itoh S; Takeda S
Acta Obstet Gynecol Scand; 2007; 86(9):1145-6. PubMed ID: 17712660
[No Abstract] [Full Text] [Related]
44. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome.
Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M
J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253
[TBL] [Abstract][Full Text] [Related]
45. Complete congenital heart block followed by anti-Ro/SSA in adult life. Studies of an informative family.
Reichlin M; Friday K; Harley JB
Am J Med; 1988 Feb; 84(2):339-44. PubMed ID: 3261539
[TBL] [Abstract][Full Text] [Related]
46. [Soluble SS-A, SS-B and RNP antinuclear antigen antibodies in 66 cases of pure or associated forms of Gougerot-Sjögren syndrome].
Meyer O; Chabrand-Ahond L; Kahn MF; Ryckewaert A
Rev Rhum Mal Osteoartic; 1982 May; 49(6):421-5. PubMed ID: 6810443
[TBL] [Abstract][Full Text] [Related]
47. Dermatitis herpetiformis and Sjögren's syndrome.
Fraser NG; Rennie AG; Donald D
Br J Dermatol; 1979 Feb; 100(2):213-5. PubMed ID: 311650
[TBL] [Abstract][Full Text] [Related]
48. Complete heart block in a fetus associated with maternal Sjögren's syndrome.
Veille JC; Sunderland C; Bennett RM
Am J Obstet Gynecol; 1985 Mar; 151(5):660-1. PubMed ID: 3872074
[TBL] [Abstract][Full Text] [Related]
49. Clinical significance of maternal anti-Ro/SS-A antibodies in children with isolated heart block.
Frohn-Mulder IM; Meilof JF; Szatmari A; Stewart PA; Swaak TJ; Hess J
J Am Coll Cardiol; 1994 Jun; 23(7):1677-81. PubMed ID: 8195531
[TBL] [Abstract][Full Text] [Related]
50. Pinguecula and Sjögren's syndrome: two cases.
de Roux-Serratrice C; Conrath J; Serratrice J; Granel B; Disdier P; Weiller PJ
Lupus; 2001; 10(5):368-9. PubMed ID: 11403269
[TBL] [Abstract][Full Text] [Related]
51. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
[TBL] [Abstract][Full Text] [Related]
52. Ro/SSA and La/SSB specific IgA autoantibodies in serum of patients with Sjögren's syndrome and systemic lupus erythematosus.
Pourmand N; Wahren-Herlenius M; Gunnarsson I; Svenungsson E; Löfström B; Ioannou Y; Isenberg DA; Magnusson CG
Ann Rheum Dis; 1999 Oct; 58(10):623-9. PubMed ID: 10491361
[TBL] [Abstract][Full Text] [Related]
53. Sjögren's syndrome in seronegative spondyloarthropathies: an unusual finding.
Gusis SE; Villa NG; Maldonado Cocco JA; Barceló HA; Scheines EJ; Catoggio LJ; Moreno C; Ravaglia C; Palioni J
J Rheumatol; 1994 Apr; 21(4):771-2. PubMed ID: 8035411
[No Abstract] [Full Text] [Related]
54. Hepatitis C virus infection and primary Sjögren's syndrome: a clinical and serologic description of 9 patients.
Ceribelli A; Cavazzana I; Cattaneo R; Franceschini F
Autoimmun Rev; 2008 Dec; 8(2):92-4. PubMed ID: 18692602
[TBL] [Abstract][Full Text] [Related]
55. Prediction of Sjögren's Syndrome Years Before Diagnosis and Identification of Patients With Early Onset and Severe Disease Course by Autoantibody Profiling.
Theander E; Jonsson R; Sjöström B; Brokstad K; Olsson P; Henriksson G
Arthritis Rheumatol; 2015 Sep; 67(9):2427-36. PubMed ID: 26109563
[TBL] [Abstract][Full Text] [Related]
56. Novel autoantibodies in Sjogren's syndrome.
Shen L; Suresh L; Lindemann M; Xuan J; Kowal P; Malyavantham K; Ambrus JL
Clin Immunol; 2012 Dec; 145(3):251-5. PubMed ID: 23123440
[TBL] [Abstract][Full Text] [Related]
57. Anti Ro/La antibodies and their clinical association.
Ben-Chetrit E
Isr J Med Sci; 1997 Apr; 33(4):251-3. PubMed ID: 9347873
[No Abstract] [Full Text] [Related]
58. Analysis of TNFalpha microsatellites in 35 patients with primary Sjögren's syndrome.
Guggenbuhl P; Veillard E; Quelvenec E; Jego P; Semana G; Jean S; Meadeb J; Chalès G; Perdriger A
Joint Bone Spine; 2000; 67(4):290-5. PubMed ID: 10963076
[TBL] [Abstract][Full Text] [Related]
59. Outcome in 212 anti-Ro/SSA-positive pregnancies and population-based incidence of congenital heart block.
Skog A; Lagnefeldt L; Conner P; Wahren-Herlenius M; Sonesson SE
Acta Obstet Gynecol Scand; 2016 Jan; 95(1):98-105. PubMed ID: 26411741
[TBL] [Abstract][Full Text] [Related]
60. [Intrauterine therapy and outcome in four pregnancies of one mother with anti ro-autoantibody positive Sjoegren's syndrome].
Zemlin M; Bauer K; Dörner T; Altinöz H; Versmold H
Z Geburtshilfe Neonatol; 2002; 206(1):22-5. PubMed ID: 11887252
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
